Salganik MP - Search Results

1

The HLDA8 blind panel: findings and conclusions.

Swart B, Salganik MP, Wand MP, Tinckam K, Milford EL, Drbal K, Angelisova P, Horejsi V, Macardle P, Bailey S, Hollemweguer E, Hodge G, Nairn J, Millard D, Dagdeviren A, Dandie GW, Zola H; HLDA8 blind panel. Swart B, et al. Among authors: salganik mp. J Immunol Methods. 2005 Oct 20;305(1):75-83. doi: 10.1016/j.jim.2005.07.003. Epub 2005 Aug 15. J Immunol Methods. 2005. PMID: 16126219

2

Detecting antibodies with similar reactivity patterns in the HLDA8 blind panel of flow cytometry data.

Salganik MP, Hardie DL, Swart B, Dandie GW, Zola H, Shaw S, Shapiro H, Tinckam K, Milford EL, Wand MP. Salganik MP, et al. J Immunol Methods. 2005 Oct 20;305(1):67-74. doi: 10.1016/j.jim.2005.07.002. Epub 2005 Aug 2. J Immunol Methods. 2005. PMID: 16129446

3

Classifying antibodies using flow cytometry data: class prediction and class discovery.

Salganik MP, Milford EL, Hardie DL, Shaw S, Wands MP. Salganik MP, et al. Biom J. 2005 Oct;47(5):740-54. doi: 10.1002/bimj.200310142. Biom J. 2005. PMID: 16385913

4

Molecular identification using flow cytometry histograms and information theory.

Zeng Q, Young AJ, Boxwala A, Rawn J, Long W, Wand M, Salganik M, Milford EL, Mentzer SJ, Greenes RA. Zeng Q, et al. Proc AMIA Symp. 2001:776-80. Proc AMIA Symp. 2001. PMID: 11825291 Free PMC article.

5

Effect of succimer on growth of preschool children with moderate blood lead levels.

Peterson KE, Salganik M, Campbell C, Rhoads GG, Rubin J, Berger O, Ware JH, Rogan W. Peterson KE, et al. Environ Health Perspect. 2004 Feb;112(2):233-7. doi: 10.1289/ehp.6331. Environ Health Perspect. 2004. PMID: 14754579 Free PMC article. Clinical Trial.

6

Early intervention in low birth weight premature infants: results at 18 years of age for the Infant Health and Development Program.

McCormick MC, Brooks-Gunn J, Buka SL, Goldman J, Yu J, Salganik M, Scott DT, Bennett FC, Kay LL, Bernbaum JC, Bauer CR, Martin C, Woods ER, Martin A, Casey PH. McCormick MC, et al. Pediatrics. 2006 Mar;117(3):771-80. doi: 10.1542/peds.2005-1316. Pediatrics. 2006. PMID: 16510657

7

The effect of chelation on blood pressure in lead-exposed children: a randomized study.

Chen A, Rhoads GG, Cai B, Salganik M, Rogan WJ. Chen A, et al. Environ Health Perspect. 2006 Apr;114(4):579-83. doi: 10.1289/ehp.8634. Environ Health Perspect. 2006. PMID: 16581549 Free PMC article. Clinical Trial.

8

Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.

Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL; Treatment of Lead-Exposed Children Clinical Trial Group. Dietrich KN, et al. Pediatrics. 2004 Jul;114(1):19-26. doi: 10.1542/peds.114.1.19. Pediatrics. 2004. PMID: 15231903 Clinical Trial.

9

The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.

Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ Jr, Rhoads GG; Treatment of Lead-Exposed Children Trial Group. Rogan WJ, et al. N Engl J Med. 2001 May 10;344(19):1421-6. doi: 10.1056/NEJM200105103441902. N Engl J Med. 2001. PMID: 11346806 Free article. Clinical Trial.

10

Assessing youth risk behavior in a clinical trial setting: lessons from the infant health and development program.

Woods ER, Buka SL, Martin CR, Salganik M, Howard MB, Gueguen JA, Brooks-Gunn J, McCormick MC. Woods ER, et al. J Adolesc Health. 2010 May;46(5):429-36. doi: 10.1016/j.jadohealth.2009.10.010. Epub 2009 Dec 29. J Adolesc Health. 2010. PMID: 20413078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page